Piramal Pharma Limited (PPLPHARMA) — Cash Flow Reinvestment Rate
Piramal Pharma Limited (PPLPHARMA) has a Cash Flow Reinvestment Rate of 0.49x as of September 2025, reinvesting Rs4.33 Billion (capex Rs4.33 Billion ) from operating cash flow of Rs8.90 Billion. Explore capital reinvestment ratio of Piramal Pharma Limited to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Piramal Pharma Limited Cash Flow Reinvestment Rate (2021–2026)
Historical reinvestment intensity for Piramal Pharma Limited across 6 annual periods. Also explore how large is Piramal Pharma Limited's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Piramal Pharma Limited (2021–2026)
Year-by-year capital reinvestment analysis for Piramal Pharma Limited. For live market cap and broader valuation context, see Piramal Pharma Limited stock valuation.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.64x | Rs8.95 Billion | Rs14.00 Billion | Rs8.90 Billion | ▼ -50.0% |
| 2025 | 1.28x | Rs11.42 Billion | Rs8.92 Billion | Rs6.64 Billion | ▲ +12.2% |
| 2024 | 1.14x | Rs11.46 Billion | Rs10.05 Billion | Rs7.12 Billion | ▼ -76.0% |
| 2023 | 4.76x | Rs23.04 Billion | Rs4.84 Billion | Rs9.65 Billion | ▼ -39.6% |
| 2022 | 7.89x | Rs20.13 Billion | Rs2.55 Billion | Rs2.01 Billion | ▼ -93.8% |
| 2021 | 127.91x | Rs44.41 Billion | Rs347.20 Million | Rs581.10 Million | — |